Navigation Links
GlobalSign Releases Code Signing Certificates for Individual Software Developers
Date:3/2/2010

GlobalSign’s publicly trusted Code Signing Certificates now available to qualified Independent Software Developers.

RSA San Francisco, CA (PRWEB) March 2, 2010 -- GlobalSign Inc (www.globalsign.com), one of the longest established Certification Authorities (CA) and specialists in supplying Digital Identities used to authenticate the publisher of software and produce tamper evident virtual “shrink-wrapped” software, has today announced the introduction of GlobalSign’s Code Signing Certificates for Individual Developers. GlobalSign Code Signing Certificates support many popular developer platforms ranging from Microsoft Authenticode (including the new Windows 7 and VBA) to Adobe AIR.

Up until recently, developers of downloadable software had little choice on how to secure their application, protect their brand identity, and reduce download abandonment due to un-trusted warning messages that result from unsigned or self-signed code. More and more operating systems insist that code available for installation be digitally signed to provide the recipient assurances that the identity of the publisher has been verified by an independent and trusted source and that the code was not altered after it was signed. Pop-ups ranging from Running Unsigned Code / Executables can be dangerous! to Publisher = Unknown; “Are you sure you want to install this application to you computer have significant negative business impact, slowing distribution as would-be installers are cautioned to pause or even abandon installation completely.

GlobalSign will continue to offer Code Signing Certificates to publishers affiliated with legal organizations such as enterprise, educational institutes, and government entities; however independent software developers will now be provided an alternativ
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
2. DFLabs Releases IncMan version 3.0 of its Information Security Incident Management Suite
3. National Council on Aging Releases Survey on Medical Imaging Safety
4. IOM report on reducing hypertension releases Feb. 22
5. International Insurance Group, Inc. Releases First Quarter 2010 Newsletters
6. Groundbreaking Principal and Contributor on Dr. Oz Show Releases His Latest Book on How We Can Influence the Lives of Children
7. SnapSports Releases ReActive Court Surfacing For The International Sports Market
8. NuSil Technology Releases a Low Coefficient of Friction Silicone Coating for Healthcare Applications
9. People-OnTheGo Releases The Accomplishing More With Less Workbook Paperback, Kindle Edition and Free e-Book
10. ckwrites.com Releases Report On Creating Online Marketing Tactics
11. Purity Products Releases Their Next Generation Lycopene Omega-3 Super Formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... Join Luz Delia ... healthfulness. Gerber believes that Well-Being begins with understanding how the body actually works. A ... of healthfulness within. Guests will receive tips on how to forge this new relationship ...
(Date:7/29/2015)... Foxborough, MA (PRWEB) , ... July 29, 2015 , ... ... at Gillette Stadium featuring Brazil vs. USA . , The international ... 2015, it has grown exponentially and now on September 8th, one of the world’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA ... five-year period, expiring November 30, 2019, during its recent meeting. , The Commission ... demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation of Certification ...
(Date:7/29/2015)... ... 2015 , ... On July 26th the Miami Herald ... nicotine laced liquid products. Their report says cigarette use has decreased recently to ... troublesome to addiction professionals as many of the candy flavors available are too ...
(Date:7/29/2015)... ... July 29, 2015 , ... With a new community ... with Stillwaters Cancer Support Services and announced a new charity campaign to raise ... counseling, support groups, workshops and educational programs at no charge. Scott Campbell ...
Breaking Medicine News(10 mins):Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3
... to believe or disbelieve a statement is a powerful ... basis of these states in the brain is not ... and uncertainty activate distinct regions of the brain, with ... and odors. The study will publish online in the ...
... 17.6 Month Overall Survival Advantage in Elderly Myeloma ... Thalidomide Is Added to Standard Therapy - Data ... ATLANTA, Dec. 9 Pharmion Corporation (Nasdaq:,PHRM) today ... trial demonstrating that the addition of,Thalidomide to standard treatment ...
... Other blood cancer treatment advances announced at hematology meeting ... are reporting what appears to be a cure for ... as incurable until now. , A complex regimen that ... better than 60 percent in 159 people with mantle ...
... A federal court in Los Angeles has,opened the ... pharmaceutical firm,Johnson & Johnson, whose subsidiary McNeil Nutritionals ... sweetener Splenda. United,States District Dale S. Fischer rejected ... that charge that the plaintiffs had unreasonably,delayed bringing ...
... -- Results from two investigational Phase I trials of ... activity in patients with relapsed and/or refractory multiple myeloma. ... 21 (48 percent) evaluable patients had a partial or ... Data from a second study, sponsored by the ...
... may be able to develop an antidepressant which takes ... the brain instead of taking a less direct route, ... take effect, according to a new study presented at ... antidepressant is also thought to be effective in people ...
Cached Medicine News:Health News:Belief, disbelief and uncertainty activate distinct brain regions 2Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 2Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 3Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 4Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 5Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 6Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 7Health News:Possible Cure for Rare Lymphoma Reported 2Health News:Possible Cure for Rare Lymphoma Reported 3Health News:Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Study shows new strategy for developing antidepressants 2Health News:Study shows new strategy for developing antidepressants 3
(Date:7/29/2015)... FRANCISCO , July 29, 2015   KaloBios ... antibody company focused on developing innovative therapies to benefit ... focus on oncology, announced today that the U.S. Food ... new drug (IND) application for KB003, an anti-GM-CSF monoclonal ... and that the IND is now active. ...
(Date:7/29/2015)... 2015  Ortho-Clinical Diagnostics, Inc. (OCD) today announced the ... assays address a range of important tests for clinical ... I. The scientific posters will be delivered during the ... be held July 26 - 30 in ... Diagnostics is emerging stronger than ever since becoming a ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( ... "Global Neurostimulation Devices Market 2015" report ... the global neurostimulation devices market to grow at ... The report, Global Neurostimulation Devices Market ... market analysis with inputs from industry experts. The ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2
... SAN DIEGO and JERUSALEM, May 17, 2012  Ambit Biosciences ... ) ("Teva") today announced the clearance of an Investigational New ... Administration (FDA) for CEP-32496, a novel BRAF (V600E) kinase inhibitor.  ... promising therapeutic potential for this agent, as evidenced by ...
... May 17, 2012 - Atu027, a First ... Activity in Cancer Patients and Possible Biomarker Identified ... of Atu027 in Solid Tumours At 2012 ASCO Annual Meeting ... "Company"), a leading global RNA interference (RNAi) therapeutics company, today ...
Cached Medicine Technology:Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 2Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 3Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 4Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 5New Data from Silence's Atu027 Anticancer Trial Published at ASCO 2New Data from Silence's Atu027 Anticancer Trial Published at ASCO 3New Data from Silence's Atu027 Anticancer Trial Published at ASCO 4New Data from Silence's Atu027 Anticancer Trial Published at ASCO 5
...
... designed for patient comfort as well as dependable ... at 5cm intervals and line marked each centimeter., ... available spanning most clinical needs and the range ... or two sensors., ,A range of four ...
... The Standard VersaFlex™ disposable pH ... nurses, and clinics worldwide for evaluating ... catheters for 24-hour esophageal pH monitoring. ... the smallest diameter esophageal catheter on ...
FLEXILOG accessory....
Medicine Products: